REG - Directa Plus PLC - Award of Options

Directa PlusAnnouncement

17/06/2021 15:50

RNS Number : 2967C
  
Directa Plus PLC
  
17 June 2021
  
 

17 June 2021
 
Directa Plus plc
("Directa Plus" or the "Company")
 
Grant of Options
 
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that, on 15 June 2021, the Board approved the grant of performance-related options over a total of 150,000 ordinary shares of 0.25 pence each in the Company (the "Options") to Giorgio Bonfanti, Chief Financial Officer under the 2020 Employees' Share Scheme. 
 
Subject to the satisfaction of criteria related to the Company's share price performance over the period, the Options (or a portion thereof) will vest in three equal tranches on each of the first, second and third anniversaries of the date of award. 75 per cent. of the vested Options may be exercised after the third anniversary and the remaining 25 per cent. may be exercised after the fourth anniversary. The exercise price of each Option will be 118.20 pence, which is the average closing bid price of the Company's shares on the London Stock Exchange plc for the 30 days before the date of grant.
 
For further information please visit http://www.directa-plus.com/ or contact:
 



Directa Plus plc


+39 02 36714458




Giulio Cesareo, CEO
Giorgio Bonfanti, CFO


















Cenkos Securities plc (Nominated Adviser and Joint Broker)


+44 131 220 6939




Neil McDonald
Pete Lynch


 




 


 




N+1 Singer (Joint Broker)


+44 20 7496 3069




Rick Thompson
Phil Davies


 




 


 




Tavistock (Financial PR and IR)


+44 20 7920 3150




Simon Hudson
Heather Armstrong


 



 
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product), textiles (based on our G+® products) and, more recently, lithium-sulphur batteries.  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products.  All our products are hypoallergenic, non-toxic and sustainably produced.
 
 



1


Details of the person discharging managerial responsibilities/person closely associated
 




a)


Name
 


Giorgio Bonfanti




2


Reason for notification
 




a)


Position/Status
 


Chief Financial Officer




b)


Initial notification/Amendment
 


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 




a)


Name
 


Directa Plus plc




b)


LEI
 


213800X2DQST3K5ND898




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 




a)


Description of the financial instrument, type of instrument
 
 


Grant of options under the Directa Plus plc 2020 Employees' Share Scheme




Identification code
 


ISIN: GB00BSM98843




b)


Nature of the transaction
 


Award of Share Options
 




c)


Price(s) and volume(s)
 


Price


Volume




118.2p


150,000




d)


Aggregated information
-       Aggregated volume
-       Price
 


N/A Single Transaction
 




e)


Date of the transaction
 


15 June 2021




f)


Place of the transaction
 


London Stock Exchange, AIM



 
-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHDKOBQQBKDAAD